ReviewCurrent opinion in rheumatology2013

Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis.

Iris Navarro-Millán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.